14 results
20-F
2021 FY
IINN
Inspira Technologies Oxy B.H.N. Ltd
31 Mar 22
Annual report (foreign)
4:48pm
believe that due to the potential ease of use and affordability of the ART, we will also be able to target smaller urban and rural hospitals that do
424B4
IINN
Inspira Technologies Oxy B.H.N. Ltd
15 Jul 21
Prospectus supplement with pricing info
4:06pm
or similar foreign regulatory bodies, we believe that due to the potential ease of use and affordability of the ART500, we will also be able to target … by the FDA or similar foreign regulatory bodies, we believe that due to the potential ease of use and affordability of the ART500, we will also be able
F-1/A
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Jul 21
Registration statement (foreign) (amended)
11:58am
foreign regulatory bodies, we believe that due to the potential ease of use and affordability of the ART500, we will also be able to target smaller … or approved by the FDA or similar foreign regulatory bodies, we believe that due to the potential ease of use and affordability of the ART500, we
F-1/A
a199g5
28 Jun 21
Registration statement (foreign) (amended)
11:41am
F-1/A
y4rmj yzojeg3q
8 Jun 21
Registration statement (foreign) (amended)
5:26pm
F-1/A
t2io wg3r
29 Mar 21
Registration statement (foreign) (amended)
5:19pm
F-1/A
ykbptn5ux6
22 Mar 21
Registration statement (foreign) (amended)
11:24am
F-1
5tu5x5sdabqi xt
5 Mar 21
Registration statement (foreign)
3:03pm
DRSLTR
pqvy53
17 Feb 21
Correspondence regarding draft registration statement
12:00am
DRS/A
4bmkb5u55pfwso0kd0
17 Feb 21
Draft registration statement (amended)
12:00am
UPLOAD
b084o5gab6ema
28 Jan 21
Letter from SEC
12:00am
DRS
hoo 9hy7jsti785
29 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next